Lyrical Asset Management LP trimmed its position in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 5.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 715,119 shares of the company’s stock after selling 37,350 shares during the quarter. HCA Healthcare accounts for 4.6% of Lyrical Asset Management LP’s portfolio, making the stock its 7th largest position. Lyrical Asset Management LP’s holdings in HCA Healthcare were worth $333,860,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently made changes to their positions in HCA. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare during the third quarter valued at $26,000. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare during the fourth quarter valued at $29,000. Ares Financial Consulting LLC bought a new position in shares of HCA Healthcare during the fourth quarter valued at $31,000. JPL Wealth Management LLC bought a new position in shares of HCA Healthcare during the third quarter valued at $33,000. Finally, Aventura Private Wealth LLC bought a new position in shares of HCA Healthcare during the fourth quarter valued at $34,000. 62.73% of the stock is owned by institutional investors.
Analysts Set New Price Targets
A number of research analysts have issued reports on the company. Argus cut their price objective on HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a report on Monday, May 4th. Barclays lowered their target price on HCA Healthcare from $551.00 to $496.00 and set an “overweight” rating for the company in a research note on Monday, April 27th. Truist Financial set a $413.00 target price on HCA Healthcare in a research note on Thursday. Oppenheimer lowered their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating for the company in a research note on Monday, April 27th. Finally, TD Cowen lowered their target price on HCA Healthcare from $561.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, April 27th. Sixteen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $506.14.
More HCA Healthcare News
Here are the key news stories impacting HCA Healthcare this week:
- Positive Sentiment: HCA reported first-quarter 2026 revenue of $19.1 billion, highlighting continued top-line growth and reinforcing the company’s scale and demand trends. HCA Healthcare (HCA) Reports Q1 2026 Financial Growth With $19.1B in Revenue
- Positive Sentiment: HCA acquired 17 urgent care clinics in the Carolinas, a move that expands its outpatient network and could support future patient volume and revenue growth. HCA acquires 17 urgent care clinics in the Carolinas
- Positive Sentiment: HCA Healthcare-owned Galen College of Nursing opened a new campus near Space Center Houston, which may help strengthen the company’s nursing pipeline and ease labor constraints over time. HCA Healthcare-owned nursing college opens new campus near Space Center Houston
- Neutral Sentiment: HCA Houston Healthcare Clear Lake is hosting a ribbon cutting for a blood cancer unit, a local service expansion that is positive operationally but likely limited in near-term stock impact. HCA Houston Healthcare Clear Lake to host ribbon cutting for blood cancer unit
- Neutral Sentiment: Additional community and employee-related announcements, including a butterfly release event and leadership updates, are supportive of HCA’s brand but are not likely to move the stock materially. HCA Florida Healthcare hosts a butterfly release to honor cancer patients and their loved ones
- Neutral Sentiment: HCA also hosted emergency response team training, which reflects ongoing operational readiness but is not a major financial catalyst. HCA Healthcare hosts emergency response team training at Tristar Skyline Medical Center
HCA Healthcare Stock Up 0.0%
HCA Healthcare stock opened at $372.29 on Monday. The business’s 50-day simple moving average is $439.51 and its 200 day simple moving average is $477.20. The stock has a market cap of $82.59 billion, a price-to-earnings ratio of 12.80, a P/E/G ratio of 1.18 and a beta of 1.12. HCA Healthcare, Inc. has a 12-month low of $330.00 and a 12-month high of $556.52.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.19 by ($0.04). The firm had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. HCA Healthcare’s revenue was up 4.3% on a year-over-year basis. During the same quarter in the prior year, the business earned $6.45 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts expect that HCA Healthcare, Inc. will post 30.07 EPS for the current year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Tuesday, June 16th will be issued a $0.78 dividend. The ex-dividend date is Tuesday, June 16th. This represents a $3.12 annualized dividend and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.73%.
HCA Healthcare Profile
HCA Healthcare is a for?profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- These 3 Insurance Stocks Made New 52-Week Highs: Still Time to Buy?
- 3 Stocks Under $20 to Buy Before a Broader Market Rally
- Petco Faces Tough Competition, But Momentum Is Building
- The Lock-In Effect Is Real—These 3 Homebuilders Are Betting on It
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
